| P50 | author | Ben J H M Poorthuis | Q130271093 |
| | Frans Walther | Q42581609 |
| P2093 | author name string | Aeilko H Zwinderman | |
| | Alfred Bernard | |
| | Howard M Berger | |
| | Alexandra J J Schrama | |
| P2860 | cites work | Quantification of Clara cell protein in rat and mouse biological fluids using a sensitive immunoassay | Q74575604 |
| | Serum Clara cell protein (CC16), a marker of the integrity of the air-blood barrier in sarcoidosis | Q74598090 |
| | A role for phospholipase A2 in ARDS pathogenesis | Q77875008 |
| | Lung epithelium-specific proteins: characteristics and potential applications as markers | Q77932822 |
| | Clara cell protein as a marker of Clara cell damage and bronchoalveolar blood barrier permeability | Q78023863 |
| | Summary proceedings from the bronchopulmonary dysplasia group | Q79733546 |
| | Circulating neutrophil concentration and respiratory distress in premature infants | Q33884689 |
| | Clara cell secretory protein (CC16): features as a peripheral lung biomarker | Q34148872 |
| | Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia | Q34446393 |
| | Antenatal factors and the development of bronchopulmonary dysplasia | Q35095591 |
| | Control of phospholipase A2 activities for the treatment of inflammatory conditions | Q36595394 |
| | The safety, pharmacokinetics, and anti-inflammatory effects of intratracheal recombinant human Clara cell protein in premature infants with respiratory distress syndrome | Q40437260 |
| | Therapeutic time-window of a group IIA phospholipase A2 inhibitor in rabbit acute lung injury: correlation with lung surfactant protection | Q43617631 |
| | Clara cell secretory protein: determination of serum levels by an enzyme immunoassay and its importance as an indicator of bronchial asthma in children | Q43624633 |
| | Clara cell secretory protein decreases lung inflammation after acute virus infection | Q43850474 |
| | Induction of phospholipase A2 gene expression in human hepatoma cells by mediators of the acute phase response | Q44780199 |
| | Recombinant human Clara cell secretory protein in acute lung injury of the rabbit: effect of route of administration | Q47694467 |
| | Effects of an intratracheally delivered anti-inflammatory protein (rhCC10) on physiological and lung structural indices in a juvenile model of acute lung injury | Q47714466 |
| | CC10 administration to premature infants: in search of the "silver bullet" to prevent lung inflammation | Q47800718 |
| | Altered pulmonary response to hyperoxia in Clara cell secretory protein deficient mice. | Q50938946 |
| | Safety and efficacy of intratracheal recombinant human Clara cell protein in a newborn piglet model of acute lung injury. | Q51666981 |
| | Severe fibronectin-deposit renal glomerular disease in mice lacking uteroglobin. | Q52194425 |
| | Detection of a rabbit uteroglobin-like protein in human neonatal tracheobronchial washings. | Q52251640 |
| | The Influence of Gestation and Mechanical Ventilation on Serum Clara Cell Secretory Protein (CC10) Concentrations in Ventilated and Nonventilated Newborn Infants | Q60495462 |
| | Factors related to the appearance of alveolar macrophages in the developing lung | Q69944719 |
| | Cord-Blood Total Protein Level as a Screening Aid for the Idiopathic Respiratory-Distress Syndrome | Q70381646 |
| | Potential role of Clara cell protein, an endogenous phospholipase A2 inhibitor, in acute lung injury | Q70963322 |
| | Cytologic evaluation of pulmonary effluent in neonates with respiratory distress syndrome and bronchopulmonary dysplasia | Q72027155 |
| | Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates | Q72379898 |
| | Clara cell protein in human amniotic fluid: a potential marker of fetal lung growth | Q72650591 |
| | Serial serum total protein values in premature infants with and without the respiratory distress syndrome | Q72819177 |
| | Number and activation of circulating polymorphonuclear leukocytes and platelets are associated with neonatal respiratory distress syndrome severity | Q73254822 |
| | Clara-cell secretory protein in preterm infants' tracheal aspirates correlates with maturity and increases in infection | Q73276528 |
| | Phospholipase A2 is present in meconium and inhibits the activity of pulmonary surfactant: an in vitro study | Q73828097 |
| | Clara cell secretory protein oxidation and expression in premature infants who develop bronchopulmonary dysplasia | Q74129602 |
| P433 | issue | 11 | |
| P921 | main subject | bronchopulmonary dysplasia | Q922640 |
| P304 | page(s) | 1305-1312 | |
| P577 | publication date | 2008-06-03 | |
| P1433 | published in | European Journal of Pediatrics | Q15755736 |
| P1476 | title | Cord blood Clara cell protein CC16 predicts the development of bronchopulmonary dysplasia | |
| P478 | volume | 167 | |